Medical marijuana Marijuana is a controlled substance in

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
330
Medical marijuana

Marijuana is a controlled substance in the U.S. and Federal law prohibits its use for any reason. Many states, however, allow medical use of marijuana to treat pain, nausea and other symptoms. The prohibition on marijuana has caused companies and research facilities to refer to medical marijuana as only hemp derived compounds . However, marijuana itself is claimed to have medicinal merit, and if Federal law permits and provides money for more research, additional benefits will likely be found.

Posted By Mayo Clinic Staff

Medical marijuana — also called medical cannabis — is a term for derivatives of the Cannabis sativa plant that are used to relieve serious and chronic symptoms.

Cannabis sativa contains many active compounds, but two are of interest for medical purposes: THC (delta-9 tetrahydrocannabinol) and CBD (cannabidiol). THC is the primary ingredient in marijuana that makes people "high."

Is medical marijuana legal in the U.S.?

U.S. federal law prohibits the use of whole plant Cannabis sativa or its derivatives for any purpose. CBD derived from the hemp plant (< 0.3% THC) is legal under federal law to consume.

Many states allow THC use for medical purposes. Federal law regulating marijuana supersedes state laws. Because of this, people may still be arrested and charged with possession in states where marijuana for medical use is legal.

When is medical marijuana appropriate?

Studies report that medical cannabis has possible benefit for several conditions. State laws vary in which conditions qualify people for treatment with medical marijuana. If you're considering marijuana for medical use, check your state's regulations.

Depending on the state, you may qualify for treatment with medical marijuana if you meet certain requirements and have a qualifying condition, such as:
• Alzheimer's disease
• Amyotrophic lateral sclerosis (ALS)
• HIV/AIDS
• Cancer
• Crohn's disease
• Epilepsy and seizures
• Glaucoma
• Multiple sclerosis and muscle spasms
• Severe and chronic pain
• Severe nausea

If you are experiencing uncomfortable symptoms or side effects of medical treatment, especially pain and nausea, talk with your doctor about all your options before trying marijuana. Doctors may consider medical marijuana as an option if other treatments haven't helped.

Is medical marijuana safe?

Further study is needed to answer this question, but possible side effects of medical marijuana may include:
• Increased heart rate
• Dizziness
• Impaired concentration and memory
• Slower reaction times
• Negative drug-to-drug interactions
• Increased risk of heart attack and stroke
• Increased appetite
• Potential for addiction
• Cyclic vomiting syndrome
• Hallucinations or mental illness
• Withdrawal symptoms

Is medical marijuana available as a prescription medicine?

The U.S. Food and Drug Administration (FDA) has approved one cannabis-derived and three cannabis-related drugs: dronabinol (Marinol, Syndros), nabilone (Cesamet) and cannabidiol (Epidiolex).

Dronabinol and nabilone can be prescribed for the treatment of nausea and vomiting caused by chemotherapy and for the treatment of anorexia associated with weight loss in people with AIDS. Cannabidiol can be prescribed for treatment of severe forms of childhood epilepsy.

What you can expect

Medical marijuana comes in a variety of forms, including:
• Oil for vaporizing
• Pill
• Topical applications
• Oral solution
• Dried leaves and buds

How and where you purchase these substances legally varies among the states that allow medical use of marijuana. Once you have the product, you administer it yourself. How often you use it depends on its form and your symptoms.

Your symptom relief and side effects also will vary based upon which type you are using. The quickest effects occur with inhalation of the vaporized form. The slowest onset occurs with the pill form.

Some medical marijuana is formulated to provide symptom relief without the intoxicating, mood-altering effects associated with recreational use of marijuana.

Certification and use on Mayo Clinic campuses

Arizona, Florida and Minnesota have adopted some form of the federal Right to Try Act. This law permits access to investigational treatments, including possibly marijuana, for people with life-threatening conditions who have exhausted approved treatment options. The Right to Try Act typically does not limit in-state use to only in-state residents. Thus, people from outside your state may be allowed to visit your state to obtain services.

https://www.mayoclinic.org/healthy-lifestyle/...t-20137855






Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geopolitical Talks Shake Oil Market, Refine Stocks' Path

Updated Category News Views 77

Diplomacy Takes Center Stage So here we are again, riding the rollercoaster of geopolitics that's jerking the oil market around like a marionette. With the U.S. and Iran allegedly chatting—mind you, with a ton of smoke and mirrors through Qatar and Islamabad—every trader's watching, hoping for a ceasefire that might either stabilize or further jolt energy prices. Oil...

Continue Reading
Yum China Delivers Strong Q3 2026 Results Again

Updated Category News Views 70

A Steady March Forward for Yum China Yum China's third-quarter results reveal a company moving like a well-oiled machine, even in a turbulent market. A revenue uptick of 8% is no small feat, especially when operating under the weight of a 3% rise in system sales that neatly sidesteps the usual foreign exchange hiccups. This ain't just about keeping the lights on; it's...

Continue Reading
OSL Unveils Instant Redemption for USDGO Plus SP

Updated Category News Views 35

OSL's New Move: Instant Redemption on the Table Alright, let's chew over OSL's latest gambit—you know, those folks (HKEX: 863) who are knee-deep in the digital currency swamp. They've launched this "Instant Redemption" feature for these fancy real-world asset products, and USDGO Plus SP is right there at the forefront. Getting the Fine Print Straight Now, not just...

Continue Reading
Connecting NIH Data: Transforming Scientific Discoveries

Updated Category News Views 44

Rethinking How Research Data Drives Discovery When researchers generate truckloads of data, finding patterns that lead to breakthroughs often becomes a game of hide and seek. It's like having a jumbo puzzle with pieces scattered all over the place. Enter the NIH Common Fund Data Ecosystem—a game changer attempting to glue together these pieces across the research...

Continue Reading
Marathon Petroleum's Massive Q3 2026 Profit Surge

Updated Category News Views 46

Marathon's Profit Skyrockets Marathon Petroleum Corp. (NYSE: MPC) just pulled off a Houdini act in the third quarter of 2026, as they reported a staggering net income of $7.4 billion. Compare that to last year's third quarter profits of $1.4 billion, and it's like comparing a sumo wrestler with a featherweight fighter. This transformation isn't just a fluke, it's a result...

Continue Reading
Tom Doyle Takes Helm at Gallagher's HR Consulting

Updated Category News Views 105

Leadership Shifts in Gallagher's Upper Echelons What a shake-up at Arthur J. Gallagher & Co.! The power torch is officially passing over in its Benefits & HR Consulting Division. Come January 1, 2027, Tom Doyle is strapping in as the new CEO, taking over from William F. "Bill" Ziebell. Now, don't get too teary-eyed—Ziebell's not vanishing into thin air. Instead, he's...

Continue Reading
PASCO scientific Appoints David Lopez as New CEO

Updated Category News Views 70

New Leadership at PASCO scientific Here's the scoop: PASCO scientific is shaking things up at the top by welcoming David Lopez into the CEO chair as of October 5, 2026. Lopez comes packing over two decades of experience in education and organizational leadership. He's stepping into a legacy that's all about making science hands-on and exciting for students—not just in...

Continue Reading
Graphic Packaging's Q3 2026 Results: Mixed Signals

Updated Category News Views 81

Graphic Packaging's Financial Figures: A Rough Ride Looking at the latest numbers from Graphic Packaging (NYSE: GPK), it's clear that the packaging landscape isn’t all wrapped up in a neat bow. Sure, the top line showed a slight uptick year-on-year with net sales nudging up $2 million to $2,192 million. Volumes were up too—by 1%—but that’s barely a blip when you...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 23

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Nucleus Reveals 2026 CPQ Value Chart for Manufacturers

Updated Category News Views 63

CPQ Tech: Unpacking the 2026 Manufacturing Landscape In the cutthroat world of manufacturing, it's adapt or die. Right now, happens it's the fixers in Configure, Price, Quote (CPQ) technology, stepping in to save the day. Nucleus Research just dropped their 2026 Manufacturing CPQ Technology Value Matrix, shining a bright spotlight on who’s leading the pack and why it...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover The Sylvan Lodge: A Luxurious Getaway in Wyoming

Updated Category News Views 209

Introducing The Sylvan Lodge The Sylvan Lodge, nestled within the enchanting Snake River Sporting Club, provides an upscale retreat for those seeking an intimate escape in the stunning wilderness of Wyoming. This luxury lodge boasts serene views, a comprehensive spa, and wellness center, along with various dining experiences that elevate the guest experience to new...

Continue Reading
Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Updated Category News Views 654

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Continue Reading
Celebrating Outstanding Contributions in Dermatologic Surgery

Updated Category News Views 215

Celebrating Excellence in Dermatologic Surgery Advocacy The American Society for Dermatologic Surgery Association (ASDSA), a leading organization advocating for dermatologic surgeons and their patients, has proudly announced its annual award recipients. This announcement highlights the essential contributions made by individuals who play pivotal roles in promoting patient...

Continue Reading
Scholastic Names Chris Lick as New Executive Vice President

Updated Category News Views 467

Scholastic Appoints Chris Lick to Leadership Role Scholastic (NASDAQ: SCHL) has recently announced a significant leadership change within its ranks, as Chris Lick steps into the role of Executive Vice President, General Counsel, and Corporate Secretary. This strategic appointment marks a new chapter for Scholastic, one of the leading organizations in children's publishing...

Continue Reading
Pandora Launches Major Share Buyback Programme

Updated Category News Views 65

Pandora Unveils New Share Buyback Programme On February 7, 2024, Pandora revealed a detailed share buyback programme that underscores its dedication to enhancing shareholder value. This initiative complies with Regulation (EU) No 596/2014, which sets the standards for market abuse regulations. Aims of the Share Buyback Programme The main objective of this programme is to...

Continue Reading